PT-141 (Bremelanotide, Vyleesi) FDA-Approved PT-141 is approved in the U.S
Triple agonists: Researchers are testing tri-agonist peptides that activate GLP-1, GIP, and glucagon receptors
Proper injection technique minimizes reactions: allow the medication to reach room temperature before injecting, insert the needle at a 90-degree angle, and avoid injecting into areas with existing irritation, scars, or stretch marks
Meanwhile, at school, Kyle gives a speech calling for the end of fat shaming, which garners a positive reception
If dry mouth persists beyond 4 to 6 weeks, inform your PlexusDx care team